Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments

被引:67
作者
Honore, Patrick M. [1 ]
Jacobs, Rita [1 ]
Joannes-Boyau, Olivier [2 ]
De Regt, Jouke [1 ]
Boer, Willem [3 ]
De Waele, Elisabeth [1 ]
Collin, Vincent [4 ]
Spapen, Herbert D. [1 ]
机构
[1] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Intens Care Dept, B-1090 Brussels, Belgium
[2] Univ Bordeaux 2, Haut Leveque Univ Hosp Bordeaux, DAR 2, Pessac, France
[3] Ziekenhuis Oost Limburg, Dept Anaesthesiol & Crit Care Med, Genk, Belgium
[4] Clin Europe Site St Michel, Intens Care Unit, Brussels, Belgium
关键词
Hemofiltration; Acute Kidney Injury; Pathphysiology; Dosing; Timing; Diagnosis; Review; CRRT; Dialysis; Septic Acute Kidney Injury; Sepsis; SIRS; CRITICALLY-ILL PATIENTS; RENAL-REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; HIGH-VOLUME HEMOFILTRATION; HIGH CUTOFF HEMOFILTRATION; POLYMYXIN-B HEMOPERFUSION; INTERMITTENT HEMODIALYSIS; EARLY BIOMARKER; CYSTATIN-C;
D O I
10.1186/2110-5820-1-32
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Evidence is accumulating showing that septic acute kidney injury (AKI) is different from non-septic AKI. Specifically, a large body of research points to apoptotic processes underlying septic AKI. Unravelling the complex and intertwined apoptotic and immuno-inflammatory pathways at the cellular level will undoubtedly create new and exciting perspectives for the future development (e. g., caspase inhibition) or refinement (specific vasopressor use) of therapeutic strategies. Shock complicating sepsis may cause more AKI but also will render treatment of this condition in an hemodynamically unstable patient more difficult. Expert opinion, along with the aggregated results of two recent large randomized trials, favors continuous renal replacement therapy (CRRT) as preferential treatment for septic AKI (hemodynamically unstable). It is suggested that this approach might decrease the need for subsequent chronic dialysis. Large-scale introduction of citrate as an anticoagulant most likely will change CRRT management in intensive care units (ICU), because it not only significantly increases filter lifespan but also better preserves filter porosity. A possible role of citrate in reducing mortality and morbidity, mainly in surgical ICU patients, remains to be proven. Also, citrate administration in the predilution mode appears to be safe and exempt of relevant side effects, yet still requires rigorous monitoring. Current consensus exists about using a CRRT dose of 25 ml/kg/h in non-septic AKI. However, because patients should not be undertreated, this implies that doses as high as 30 to 35 ml/kg/h must be prescribed to account for eventual treatment interruptions. Awaiting results from large, ongoing trials, 35 ml/kg/h should remain the standard dose in septic AKI, particularly when shock is present. To date, exact timing of CRRT is not well defined. A widely accepted composite definition of timing is needed before an appropriate study challenging this major issue can be launched.
引用
收藏
页数:9
相关论文
共 101 条
[81]   Outcome comparisons of intermittent and continuous therapies in acute kidney injury: What do they mean? [J].
Ronco, C. ;
Bagshaw, S. M. ;
Gibney, R. T. N. ;
Bellomo, R. .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (03) :213-220
[82]   Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial [J].
Ronco, C ;
Bellomo, R ;
Homel, P ;
Brendolan, A ;
Dan, M ;
Piccinni, P ;
La Greca, G .
LANCET, 2000, 356 (9223) :26-30
[83]  
Ronco C, 2008, NEW ENGL J MED, V359, P1959, DOI 10.1056/NEJMc081598
[84]   Dialysis dose in acute kidney injury: no time for therapeutic nihilism - a critical appraisal of the Acute Renal Failure Trial Network study [J].
Ronco, Claudio ;
Cruz, Dinna ;
van Straaten, Helen Oudemans ;
Honore, Patrick ;
House, Andrew ;
Bin, Du ;
Gibney, Noel .
CRITICAL CARE, 2008, 12 (05) :308
[85]   The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation [J].
Santiago, Maria J. ;
Sanchez, Amelia ;
Lopez-Herce, Jesus ;
Perez, Rosario ;
del Castillo, Jimena ;
Urbano, Javier ;
Carrillo, Angel .
KIDNEY INTERNATIONAL, 2009, 76 (12) :1289-1292
[86]   Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure [J].
Saudan, P. ;
Niederberger, M. ;
De Seigneux, S. ;
Romand, J. ;
Pugin, J. ;
Perneger, T. ;
Martin, P. Y. .
KIDNEY INTERNATIONAL, 2006, 70 (07) :1312-1317
[87]   Daily hemodialysis and the outcome of acute renal failure [J].
Schiffl, H ;
Lang, SM ;
Fischer, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :305-310
[88]   Hemodynamic tolerance of intermittent hemodialysis in critically ill patients -: Usefulness of practice guidelines [J].
Schortgen, F ;
Soubrier, N ;
Delclaux, C ;
Thuong, M ;
Girou, E ;
Brun-Buisson, C ;
Lemaire, F ;
Brochard, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (01) :197-202
[89]   Need to intervene in established acute renal failure [J].
Schrier, RW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (10) :2756-+
[90]   Timing of renal replacement therapy initiation in acute renal failure: A meta-analysis [J].
Seabra, Victor F. ;
Balk, Ethan M. ;
Liangos, Orfeas ;
Sosa, Marie Anne ;
Cendoroglo, Miguel ;
Jaber, Bertrand L. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (02) :272-284